Purac and Arkema is collaborating on the development of lactide-based block copolymers that will enhance the thermochemical and physical properties of bioplastics such as polylactic acid (PLA). I remembered Arkema mentioning their one of many bioplastic additives development in a past post so I guess this is one of them.
Purac said this latest copolymers are produced by combining Arkema’s organic catalysis ring-opening polymerisation technology with Purac’s L- and D-Lactide monomers.
In the other news, Purac said it is expanding its biomedical polymers capacity by building a new manufacturing facility in the US. Capacity of the facility was not disclosed. Purac is already currently operating a biomedical polymers plant in the Netherlands.
Construction of this second facility in the US will start next year and will be completed before the end of 2011. Investment costs for the plant is around EUR 15m.